Arkolith/Insider Trading/FBIO/Form 4

Rosenwald Lindsay A MD

President, CEO & Chairman, Director, 10% OwnerFortress Biotech, Inc. (FBIO) · full profile →Form 4 · filed Nov 16, 2023
Net Buying
Open-Market Buys
$2.7M
Open-Market Sells
$0
Net Open-Market Flow
$2.7M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 14, 2023Buy(P)1.6M$1.70$2.7M2.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 14, 2023Buy(P)1.6M—$01.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-119188) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML